Marksans Pharma standalone net profit declines 58.73% in the March 2016 quarter

Sales decline 24.32% to Rs 69.43 crore

Net profit of Marksans Pharma declined 58.73% to Rs 5.08 crore in the quarter ended March 2016 as against Rs 12.31 crore during the previous quarter ended March 2015. Sales declined 24.32% to Rs 69.43 crore in the quarter ended March 2016 as against Rs 91.74 crore during the previous quarter ended March 2015.

For the full year,net profit rose 6.53% to Rs 71.49 crore in the year ended March 2016 as against Rs 67.11 crore during the previous year ended March 2015. Sales declined 11.70% to Rs 358.13 crore in the year ended March 2016 as against Rs 405.59 crore during the previous year ended March 2015.

ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales69.4391.74 -24 358.13405.59 -12 OPM %19.6222.68 -31.4429.30 - PBDT12.8019.31 -34 106.38105.72 1 PBT8.4116.90 -50 91.6396.69 -5 NP5.0812.31 -59 71.4967.11 7

Powered by Capital Market - Live News